Financial Data and Key Metrics Changes - Revenue from continuing operations increased by 3.1% in Q4 2025 compared to Q4 2024, while consolidated adjusted EBITDA rose by 7.8% [9][18] - For the full year 2025, revenue was $54.9 million, up from $52.2 million in 2024, and consolidated net income increased to $2.9 million from a loss of $5.8 million in 2024 [21][22] Business Line Data and Key Metrics Changes - System-wide sales decreased by 3.9% to $130 million in Q4 2025, with comp sales down 3.8% [18] - The total clinic count at year-end was 960, down from 967 the previous year, with 29 new clinics opened and 41 refranchised during 2025 [19] Market Data and Key Metrics Changes - The company is focusing on improving new patient acquisition through enhanced marketing strategies, shifting from local to national advertising to increase brand awareness [12][34] - New patient acquisition trends have shown improvement each month since the launch of the new marketing initiatives, although they remain lower than the previous year [14][54] Company Strategy and Development Direction - The company is on track to complete the first phase of its transformation journey, Joint 2.0, by the end of 2025, transitioning to a pure-play franchisor model [5][27] - Future growth strategies include expanding operations into new channels and markets, focusing on integrated treatments and leveraging data from wearable technology [28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving long-term goals despite current challenges, emphasizing the importance of improving marketing effectiveness and patient retention [27][62] - The company anticipates that the second half of 2026 will show improved comp sales due to easier comparisons and traction from current initiatives [51][66] Other Important Information - The company repurchased 1.1 million shares for $9 million in Q4 2025, with a total of 1.3 million shares repurchased for $11.3 million throughout the year [9][22] - The company expects system-wide sales for 2026 to range from $519 million to $552 million, with comp sales projected between -3% to 3% [22] Q&A Session Summary Question: Can you share the attrition and new patient add metrics? - Management noted that new patient flow has been the weakest component of active member growth, but early signs from new marketing efforts are positive [31][32] Question: How are you evolving marketing initiatives for 2026? - The focus remains on shifting investment from local to national marketing, improving creative messaging, and addressing changes in search behaviors due to AI [34][35] Question: How did the three-tiered pricing pilot go? - The $10 pricing increase showed more benefit compared to the $2 increase, and further testing is ongoing before broader rollout [38][39] Question: What specific leading indicators give confidence that comps will improve in 2026? - Management highlighted early signs of improvement in leads and new patients, with expectations for better performance in the second half of the year [51][52] Question: Does your guidance include a pricing increase? - No, the guidance does not include any pricing increase as the results from recent tests were still uncertain [67]

Financial Data and Key Metrics Changes - Revenue from continuing operations increased by 3.1% in Q4 2025 compared to Q4 2024, reaching $15.2 million, while consolidated adjusted EBITDA rose by 7.8% to $3.6 million [9][20] - For the full year 2025, revenue was $54.9 million, up from $52.2 million in 2024, and consolidated net income improved to $2.9 million from a loss of $5.8 million in 2024 [21][22] - Unrestricted cash and cash equivalents at the end of Q4 2025 stood at $23.6 million, down from $25.1 million in the prior year [22] Business Line Data and Key Metrics Changes - System-wide sales decreased by 3.9% to $130 million in Q4 2025, while comp sales were down 3.8% [18] - For the full year, system-wide sales were flat at $532 million, with comp sales declining by 0.4% [18] Market Data and Key Metrics Changes - The total clinic count at year-end 2025 was 960, down from 967 clinics in the prior year, with 885 franchise clinics and 75 company-owned clinics [19] - The company refranchised 41 clinics and closed 36 clinics during 2025 [19] Company Strategy and Development Direction - The company is on track to complete the first phase of its transformation journey, Joint 2.0, by the end of 2026, transitioning to a pure-play franchisor model [5][28] - Future growth strategies include expanding operations into new channels and markets, focusing on health trends and integrated treatments [29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in improving operating leverage and financial position through refranchising and cost-saving initiatives [28] - The company anticipates that 2026 will be more profitable than 2025 due to refranchising efforts and realignment of corporate costs [24] Other Important Information - The company repurchased 1.1 million shares for $9 million in Q4 2025 and a total of 1.3 million shares for $11.3 million in 2025 [9][22] - The company expects system-wide sales in 2026 to range from $519 million to $552 million, with comp sales projected between -3% to 3% [22] Q&A Session Summary Question: Can you share the attrition and new patient add metrics? - Management noted that new patient flow has been the weakest component of active member growth, but early signs from new marketing efforts are positive [33][34] Question: How are you evolving marketing initiatives for 2026? - The focus remains on shifting investment from local to national marketing to amplify brand awareness, with ongoing adjustments to creative messaging and addressing shifts in search behaviors due to AI [36][37] Question: How did the three-tiered pricing pilot go? - The $10 pricing increase showed more benefit compared to the $2 increase, and further testing is ongoing before broader rollout [39][40] Question: How did comp sales progress throughout the quarter? - Comp sales were down the most in November but improved in December, with expectations for better performance in the second half of the year [46][47] Question: What specific leading indicators give confidence that comps will improve in 2026? - Management highlighted early signs of improvement in leads and new patient acquisition, with expectations for better performance in the second half of the year due to easier comparisons [52][55] Question: Can you elaborate on growth initiatives and capital allocation? - Investments will focus on technology improvements and user interface enhancements for Wellness Coordinators, with ongoing negotiations for RD territory buybacks [70][73]

Core Insights - The Joint Corp. will report its 2025 fourth quarter and full year financial results on March 12, 2026, after market close, followed by a conference call at 5:00 p.m. ET [1] Company Overview - The Joint Corp. is the largest franchisor of chiropractic care in the U.S., operating through The Joint Chiropractic network, with over 950 locations and more than 14 million patient visits annually [4] - The company has revolutionized access to chiropractic care since introducing its retail healthcare business model in 2010, making quality care convenient and affordable without the need for insurance [4] - The Joint Chiropractic has received multiple accolades, including being named "No. 1 in Chiropractic Services" by Entrepreneur and consistently ranking on Franchise Times' "Top 400" and "Fast & Serious" lists [4] Business Structure - The Joint Corp. operates as a franchisor and also manages clinics in certain states, providing management services to affiliated professional chiropractic practices in various states including California, Florida, and New York [5]

Core Insights - Flexible Spending Accounts (FSAs) allow employees to set aside pre-tax money for qualifying healthcare expenses, providing a tax break and reducing monthly expenses [1] - Unlike Health Savings Accounts (HSAs), FSAs have a strict deadline for spending contributions, with most 2025 FSA funds needing to be used by December 31, 2025, although some plans may offer a grace period until March 15, 2026 [2][5] - Unused FSA funds can be lost if not spent, emphasizing the importance of understanding the specific rules of the employer's plan [3] Spending Options - Employers may provide a grace period of up to 2.5 months to utilize remaining FSA funds [5] - Suggested items for spending unused FSA funds include: - Dental care services such as cleanings or fillings [6] - Over-the-counter medications [6] - Vision exams and new glasses [6] - First-aid supplies [6] - Chiropractic care [6] - Contact lenses and lens solutions [6] - Cough drops [6] - Flu shots and other vaccines [7] - Menstrual products [7] - Massage therapy [7] - A comprehensive list of eligible products and services is available through FSA Feds, encouraging users to check for regularly used items [7]

Core Insights - Palmercare Chiropractic Fairfax has achieved a milestone year with record-breaking patient volume and enhanced community involvement under the leadership of Dr. Anna Choi [1][3][4] Group 1: Patient Growth and Community Engagement - The clinic served more patients than ever in 2025, driven by strong participation in local community events and wellness initiatives [3][4] - Outreach efforts have strengthened relationships with Fairfax-area residents, reinforcing the clinic's reputation as a welcoming, patient-centered chiropractic office [3][4] Group 2: Commitment to Clinical Excellence - Dr. Anna Choi emphasized creating a supportive environment for patients, which has contributed to the clinic's growth and the trust placed in it by the community [4][9] - The clinic focuses on providing comprehensive chiropractic care aimed at helping patients achieve and maintain health through spinal alignment and nervous system function [7] Group 3: Complementary Services and Professional Development - In addition to chiropractic care, the clinic offers services such as massage therapy, physiotherapy, acupuncture, and rehabilitation to support recovery and long-term wellness [8] - Dr. Choi has prioritized continuing education and professional development to ensure the team stays updated with evolving chiropractic techniques and best practices [9] Group 4: Broader Legacy of Care - Palmercare Chiropractic operates multiple locations and has a legacy of serving over 100,000 satisfied patients across the organization [10]

Core Insights - The Joint Corp. has appointed Ron Stilwell as Senior Vice President of Operations and Patient Experience, effective immediately, to enhance operational efficiency and patient satisfaction [1][3] Company Overview - The Joint Corp. is the largest franchisor of chiropractic care in the U.S., operating through The Joint Chiropractic network, with over 950 locations and more than 14 million patient visits annually [6][7] - The company aims to provide convenient and affordable chiropractic care while eliminating the need for insurance [6] Leadership Background - Ron Stilwell brings over 30 years of experience in franchise operations, having previously served as President and Chief Development Officer at FullSpeed Automotive and held leadership roles at Marco's Pizza and Kahala Brands [2][3] - His expertise includes operational excellence, P&L management, and customer satisfaction, which are expected to contribute to The Joint's growth and profitability [2][3] Strategic Goals - The company aims to enhance patient experience, improve franchisee relations, and increase new patient acquisition under Stilwell's leadership [3] - The focus is on delivering improved outcomes to grow topline sales and enhance profitability for both franchisees and the company [3]

Core Insights - The Joint Corp. has signed an Asset Purchase Agreement to sell 22 corporate-owned or managed clinics for $1.5 million to three buying groups, with operations transitioning to the buyers in mid-December [1][3] - The company has terminated a previous APA for 45 clinics in Southern California, signed on November 2, 2025 [1] Summary of Transactions - Nine clinics will be purchased by an existing franchisee and regional developer with over 13 years of experience at The Joint, who currently owns eight other clinics in North Carolina [5] - Ten clinics in North Carolina will be acquired by a Doctor of Chiropractic and his business partner, who has over three years of operations experience within the system [5] - Three clinics in Georgia and South Carolina will be purchased by a team of two seasoned Doctors of Chiropractic, who are also franchisees at The Joint [5] Company Overview - The Joint Corp. is the largest franchisor of chiropractic care in the U.S., operating over 950 locations and facilitating more than 14 million patient visits annually [7] - The company has been recognized in various industry rankings, including Franchise Times' "Top 400" and "Fast & Serious" lists, and has been named "No. 1 in Chiropractic Services" by Entrepreneur [7] - The Joint's business model focuses on making chiropractic care convenient and affordable, eliminating the need for insurance [7][8]

Core Insights - The Joint Chiropractic is launching its annual "Back Friday" campaign to address the physical demands of the holiday season, offering additional chiropractic visits with the purchase of visit packages [1][2]. Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S., operating over 950 locations and facilitating more than 14 million patient visits annually [6]. - The company has revolutionized access to chiropractic care since 2010 by introducing a retail healthcare business model that eliminates the need for insurance [6]. - The Joint Chiropractic is recognized for its convenient services, including no appointments and affordable care, appealing to a wide demographic from children to seniors [4]. Campaign Details - The "Back Friday" campaign runs from November 17 to December 8, 2025, offering one additional visit with a 6-visit package, two additional visits with a 10-visit package, and four additional visits with a 20-visit package [2][8]. - The campaign aims to alleviate stress-related physical issues during the holidays, such as headaches and muscle tension, through chiropractic adjustments [3]. Industry Recognition - The Joint Chiropractic has been consistently ranked in various prestigious lists, including Franchise Times' "Top 400" and "Fast & Serious" lists, and has been named "No. 1 in Chiropractic Services" by Entrepreneur [6].

Financial Performance (Q3 2025) - Revenue increased by 6% to $13.4 million compared to $12.7 million in Q3 2024[31] - Consolidated Adjusted EBITDA increased by 36% to $3.3 million compared to $2.4 million in Q3 2024[28, 31] - System-wide sales decreased by (1.5)% in Q3 2025[28] - Comp sales decreased by (2.0)% in Q3 2025[28] Financial Performance (YTD 2025) - Revenue increased by 6% to $39.7 million compared to $37.4 million in YTD 2024[32] - Consolidated Adjusted EBITDA increased by 16% to $9.4 million compared to $8.1 million in YTD 2024[32] Strategic Initiatives - Focused on becoming a pure-play franchisor, actively engaged in negotiations for the balance of the corporate portfolio[12] - Launched 3 pricing pilots to inform enterprise-wide price increase in Q1 2026[21] - Revising 2025 system-wide sales guidance to $530 million - $534 million[36]

Core Viewpoint - The Joint Corp. has authorized an additional $12 million for its stock repurchase program, emphasizing its commitment to disciplined capital allocation and belief in the undervaluation of its long-term growth potential [1][2]. Company Overview - The Joint Corp. is the largest provider of chiropractic care in the U.S. through The Joint Chiropractic network, with over 950 locations and more than 14 million patient visits annually [3]. - The company operates a retail healthcare business model that eliminates the need for insurance, making chiropractic care more accessible and affordable [3]. - The Joint Corp. has received multiple accolades, including being named "No. 1 in Chiropractic Services" by Entrepreneur and consistently ranking in Franchise Times' annual lists [3]. Business Structure - The Joint Corp. functions as both a franchisor and operator of clinics in various states, providing management services to affiliated chiropractic practices [4].